ID   113F1
AC   CVCL_J910
DR   ATCC; HB-8490
DR   Wikidata; Q54580995
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US5629197;
RX   PubMed=1715033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8490.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human breast/ovarian cancer 55 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US4753894;
RA   Frankel A.E., Ring D.B., Bjorn M.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US4753894, 28-Jun-1988.
//
RX   Patent=US4938948;
RA   Ring D.B., Frankel A.E.;
RT   "Method for imaging breast tumors using labeled monoclonal anti-human
RT   breast cancer antibodies.";
RL   Patent number US4938948, 03-Jul-1990.
//
RX   Patent=US5629197;
RA   Ring D.B., Frankel A.E., Bjorn M.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US5629197, 13-May-1997.
//
RX   PubMed=1715033; DOI=10.1016/0161-5890(91)90056-p;
RA   Ring D.B., Clark R., Saxena A.;
RT   "Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal
RT   antibodies with recombinant c-erbB-2.";
RL   Mol. Immunol. 28:915-917(1991).
//